Validation of a Multidimensional Scale for the Detection of Health Needs in People With HIV

NCT ID: NCT07077642

Last Updated: 2025-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-02

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to evaluate the diagnostic performance of the multidimensional screening test in identifying alterations in the domains considered in people with HIV, in order to improve the predictivity of disorders, ensure better care and consequently improve the quality of life of people with HIV

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years and older

* Confirmed HIV infection
* Good understanding of the Italian language
* Signature of informed consent
* Inclusion of at least 33% women and at least 33% people older than 50 years of age

Exclusion Criteria

* Acute ongoing diseases that, in the opinion of the investigators, may affect the performance of the tests (bacterial or viral infections, neoplasms under active chemotherapy treatment)

* Dementia or other severe neurodegenerative/neurocognitive disorders.
* Individuals unable to express consent independently and/or supported by protective legal figures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Giovanni Di Perri

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Giovanni Di Perri

Prof.

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Università degli Studi di Genova

Genova, Genova, Italy

Site Status

ASST Fatebenefratell - Sacco, Ospedale L. Sacco

Milan, Milano, Italy

Site Status

Clinica delle Malattie Infettive e Tropicali, Dipartimento di Scienze della Salute, Università degli Studi di Milano, ASST Santi Paolo e Carlo

Milan, Milano, Italy

Site Status

Unità di Malattie Infettive, IRCCS San Raffaele

Milan, Milano, Italy

Site Status

Ospedale Amedeo di Savoia

Torino, Torino, Italy

Site Status

UOC Malattie Infettive, Università di Bari "Aldo Moro", AOU Policlinico di Bari

Bari, , Italy

Site Status

UOC Malattie Infettive, Arnas Garibaldi

Catania, , Italy

Site Status

Malattie Infettive ed Urgenze Infettivologiche, Presidio Ospedaliero Cotugno - Azienda Ospedaliera dei Colli, Napoli

Napoli, , Italy

Site Status

UOC Malattie Infettive e Tropicali, Azienda Ospedale Università di Padova

Padua, , Italy

Site Status

Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma

Roma, , Italy

Site Status

SS Immunodeficienza, Azienda Ospedaliero Universitaria di Sassari

Sassari, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MUSA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Managerial Database II
NCT01322217 COMPLETED
Comorbidity and Aging With HIV
NCT01466582 ACTIVE_NOT_RECRUITING